- MGC Diagnostics (NASDAQ:MGCD -3.5%) fiscal Q3 results: Revenues: $6.6M (-16.8%); Operating Expenses: $4.5M (+20.6%); Net Loss: ($0.9M) (-234.8%); Loss Per Share: ($0.21) (-231.3%); Quick Assets: $15.4M (+45.3%); CF Ops (9 mo.): $1.9M (+45.1%).
- No financial guidance given.